Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...
Water ablation therapy for BPH was safe and effective in real-world patients with prostate gland volumes of 80 mL or larger, even those exceeding 150 mL. Rezūm water vapor therapy is a safe and ...
GRENOBLE, France, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today passing an important ...
AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ...
Aquablation therapy is a relatively new, noninvasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Medicare covers one treatment, but conditions apply. Before ...
MINNEAPOLIS – Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to treat a common cancer with only a few drops of water, Hoey ...
Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated, or they’re serious enough to require surgery and radiation. Monitoring can cause patients anxiety.
Medicare Part B covers Aquablation for BPH if a person meets specific eligibility criteria, including a prostate volume of 30 to 150 cubic centimeters (cc). Medicare does not cover Aquablation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback